Princeton Graduate Biotechnology Club

A graduate student organization connecting the Princeton research community to the skills, people, and companies that turn scientific discovery into real-world impact.

PGBC logo: a shield with a DNA double helix

Mission Statement

Our mission is to equip the Princeton graduate research community with the knowledge, connections, and perspectives needed to understand how scientific discovery moves from the lab to industry.

Biopharma

Princeton Spinouts

Map of the biotech landscape around Princeton: Bristol Myers Squibb, Novo Nordisk, Johnson & Johnson, and Merck, Princeton spinouts ArrePath, KayoThera, and Optimeos, and the rail line to Philadelphia, New York, and Boston.

What We Do

We’re here to provide the knowledge and connections needed to understand how scientific research moves from discovery to translation, innovation, and application.

Turning scientific discovery into real-world impact requires knowledge of translational science, intellectual property, regulatory strategy, and capital: all areas this club helps students learn about and engage with.

We connect the graduate research community with founders, investors, industry scientists, and alumni. Our goal is to give students the knowledge, connections, and perspective to understand the relationship between academic research and biotechnology.

Our Programming

Monthly

Speaker Series

Biotechnology founders, industry scientists, and business leaders, paired with lunches and dinners that create space for deeper conversation and connection.

A few times a semester

Venture Capital and Startup Literacy

Practical sessions built around case studies of how scientific ideas are evaluated, financed, and developed into companies.

Once per semester

Site Visits

Visits to biotechnology companies, offering a firsthand look at how science, technology, and business come together in practice.

A few times a semester

Regulatory and IP Workshops

The regulatory and intellectual property landscape of biotechnology, including FDA approval pathways and patenting.